Persones / Equip Humà

Manuel Vázquez Carrera

Buscador de publicacions

Publicacions

  • Coll T, Jové M, Rodríguez-Calvo R, Eyre E, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.

    Diabetes . 55(10): 2779-2787. Nº de cites: 125

    [doi:10.2337/db05-1494]

  • Rodríguez-Calvo R, Jové M, Coll T, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.

    PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 61(8): 773-780. Nº de cites: 26

    [doi:10.1093/gerona/61.8.773]

  • Planavila A, Rodríguez-Calvo R, de Arriba AF, Sánchez RM, Laguna JC, Merlos M and Vazquez M.

    Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.

    MOLECULAR PHARMACOLOGY . 69(4): 1174-1181. Nº de cites: 7

    [doi:10.1124/mol.105.016345]

  • Sanguino E, Roglans N, Rodríguez-Calvo R, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Ageing introduces a complex pattern of changes in several rat brain transcription factors depending on gender and anatomical localization.

    EXPERIMENTAL GERONTOLOGY . 41(4): 372-379. Nº de cites: 8

    [doi:10.1016/j.exger.2006.02.011]

  • Llaverias G, Rebollo A, Pou J, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes.

    BIOCHEMICAL PHARMACOLOGY . 71(5): 605-614. Nº de cites: 31

    [doi:10.1016/j.bcp.2005.11.022]

  • Jové M, Planavila A, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation.

    Endocrinology . 147(1): 552-561. Nº de cites: 138

    [doi:10.1210/en.2005-0440]

  • Planavila A, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1736(2): 120-127. Nº de cites: 20

    [doi:10.1016/j.bbalip.2005.08.001]

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.

    BRITISH JOURNAL OF PHARMACOLOGY . 145(7): 853-861. Nº de cites: 48

    [doi:10.1038/sj.bjp.0706260]

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Different response of senescent female Sprague-Dawley rats to gemfibrozil and rosiglitazone administration.

    EXPERIMENTAL GERONTOLOGY . 40(7): 588-598. Nº de cites: 6

    [doi:10.1016/j.exger.2005.05.006]

  • Cabrero A, Cubero M, Llaverías G, Alegret M, Sánchez R, Laguna JC and Vazquez M.

    Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages.

    MOL CELL BIOCHEM . 275(1-2): 173-179. Nº de cites: 40

    [doi:10.1007/s11010-005-1353-8]